Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -49.27% is 20% above its 5-year average of -61.47%, near the high end of its 5-year range (-142.35%–-23.35%).
As of the fiscal period ended Tuesday, June 30, 2026. 32.54% above its 12-month average of -73.04%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -49.27%.
RETURN ON INVESTED CAPITAL (ROIC)
-49.27%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-73.04%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-63.10%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-61.47%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+32.54%
CURRENT VS 3Y AVG
+21.91%
CURRENT VS 5Y AVG
+19.84%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-33.61%
median of 724 covered companies
CURRENT VS SECTOR MEDIAN
-46.58%
vs the sector median at left
Milestone Pharmaceuticals Inc.
Market Cap
$96.80M
Return on Invested Capital (ROIC)
-49.27%
TTM Avg
-73.04%
3Y Avg
-63.10%
5Y Avg
-61.47%
Market Cap
$97.84M
Return on Invested Capital (ROIC)
-50.17%
TTM Avg
-64.75%
3Y Avg
-64.53%
5Y Avg
-48.29%
Market Cap
$98.56M
Return on Invested Capital (ROIC)
13.49%
TTM Avg
-178.47%
3Y Avg
-181.87%
5Y Avg
-147.13%
Market Cap
$97.80M
Return on Invested Capital (ROIC)
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$94.27M
Return on Invested Capital (ROIC)
-4.43%
TTM Avg
2.86%
3Y Avg
2.48%
5Y Avg
2.48%
Market Cap
$92.54M
Return on Invested Capital (ROIC)
-220.02%
TTM Avg
-209.28%
3Y Avg
-141.42%
5Y Avg
-99.57%
Market Cap
$103.09M
Return on Invested Capital (ROIC)
-82.35%
TTM Avg
-77.56%
3Y Avg
-62.72%
5Y Avg
-68.20%
Market Cap
$103.07M
Return on Invested Capital (ROIC)
5.11%
TTM Avg
-4.38%
3Y Avg
-1.84%
5Y Avg
2.15%
Market Cap
$102.56M
Return on Invested Capital (ROIC)
-35.98%
TTM Avg
-82.06%
3Y Avg
-144.65%
5Y Avg
-107.36%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Milestone Pharmaceuticals Inc. (MIST) | $96.80M | -49.27% | -73.04% | -63.10% | -61.47% |
| Korro Bio, Inc. (KRRO)vs › | $97.84M | -50.17% | -64.75% | -64.53% | -48.29% |
| PolyPid Ltd. (PYPD)vs › | $98.56M | 13.49% | -178.47% | -181.87% | -147.13% |
| Conexeu Sciences Inc. (CNXU)vs › | $97.80M | N/A | N/A | N/A | N/A |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $94.27M | -4.43% | 2.86% | 2.48% | 2.48% |
| Biomea Fusion, Inc. (BMEA)vs › | $92.54M | -220.02% | -209.28% | -141.42% | -99.57% |
| Anixa Biosciences, Inc. (ANIX)vs › | $103.09M | -82.35% | -77.56% | -62.72% | -68.20% |
| The Joint Corp. (JYNT)vs › | $103.07M | 5.11% | -4.38% | -1.84% | 2.15% |
| OnKure Therapeutics, Inc. (OKUR)vs › | $102.56M | -35.98% | -82.06% | -144.65% | -107.36% |
| Polaryx Therapeutics, Inc. Common Stock (PLYX)vs › | $105.67M | -47.75% | -127.40% | -174.63% | -174.63% |
ROIC
-49.3%
ROE
-461.1%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -49.27% |
| 2026-03-31 | -37.74% |
| 2025-12-31 | -62.07% |
| 2025-09-30 | -73.74% |
| 2025-06-30 | -142.35% |
| 2025-03-31 | -106.60% |
| 2024-12-31 | -62.49% |
| 2024-09-30 | -55.82% |
| 2024-06-30 | -57.84% |
| 2024-03-31 | -61.03% |
| 2023-12-31 | -89.85% |
| 2023-09-30 | -77.29% |
| 2023-06-30 | -66.93% |
| 2023-03-31 | -59.25% |
| 2022-12-31 | -86.64% |
| 2022-09-30 | -78.86% |
| 2022-06-30 | -71.23% |
| 2022-03-31 | -44.00% |
| 2021-12-31 | -38.09% |
| 2021-09-30 | -27.24% |
| 2021-06-30 | -23.35% |
| 2021-03-31 | -35.10% |
| 2020-12-31 | -35.26% |
| 2020-09-30 | -59.12% |
| 2020-06-30 | -70.88% |
| 2020-03-31 | -63.84% |
| 2019-12-31 | -50.29% |
| 2019-09-30 | -36.90% |
| 2019-06-30 | -28.31% |
| 2019-03-31 | -41.53% |
| 2018-12-31 | -28.51% |
